FdaApplication
ANDA 213517
Identifiers
- fda_app_no: ANDA213517
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMAZONE |
| application_type | ANDA |
| approval_date | 2022-04-27 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RANOLAZINE | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE;ORAL |
| RANOLAZINE | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE;ORAL |
2 products